Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2018

05.07.2018 | Maternal-Fetal Medicine

Neonatal outcome in gestational-diabetic mothers treated with antenatal corticosteroids delivering at the late preterm and term

verfasst von: Eyal Krispin, Alyssa Hochberg, Rony Chen, Arnon Wiznitzer, Eran Hadar, Adi Borovich

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

To determine the association between antenatal corticosteroid treatment and neonatal complications in diabetic mothers delivering after 34 weeks of gestation.

Methods

A retrospective cohort study of women with singleton pregnancies diagnosed with gestational diabetes who delivered after 34 weeks of gestation in a university-affiliated medical center (2012–2016). Mothers treated with corticosteroids prior to 34 + 0 weeks of gestation were divided according to gestational age at delivery: late-preterm (34 + 0 to 36 + 6) and term (37 + 0 to 41 + 6). Each group was compared to women delivering at the same gestational age who were not treated with corticosteroids. Primary outcome was defined as a neonatal adverse composite outcome. Birth weight was amongst secondary outcomes measured. Logistic regression analysis was utilized to adjust results to potential confounders.

Results

During the study period, 161 diabetic mothers delivered at late-preterm. Amongst them, 47 (30%) were treated with corticosteroids. 2101 diabetic mothers delivered at term, amongst them 82 (4%) were treated with corticosteroids. Primary outcome did not differ between groups. Multivariate analysis demonstrated that corticosteroid treatment was not associated with neonatal adverse composite outcome when delivery occurred at the late preterm, nor at term (adjusted odds ratio (aOR) = 0.708, 95% CI 0.2–2.3, p = 0.572, and aOR = 1.6, 95% CI 0.2–12.7, p = 0.635, respectively). Birth weight was significantly lower in women treated with corticosteroids (2486 vs. 2675 g, p = 0.02 at late-preterm, and 3160 vs. 3319 g, p < 0.001 at term).

Conclusion

Corticosteroid treatment for diabetic mothers was not associated with neonatal adverse outcomes, but was found associated with a lower birth weight, when delivery occurs after 34 weeks of gestation.
Literatur
1.
Zurück zum Zitat American College of Obstetricians and Gynecologists (2016) Periviable birth. Obstetric Care Consensus No. 4. Obstet Gynecol 127:157–169CrossRef American College of Obstetricians and Gynecologists (2016) Periviable birth. Obstetric Care Consensus No. 4. Obstet Gynecol 127:157–169CrossRef
2.
Zurück zum Zitat Carlo WA, McDonald SA, Fanaroff AA, Vohr BR, Stoll BJ, Ehrenkranz RA et al (2011) Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 5 weeks’ gestation. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. JAMA 306:234858CrossRef Carlo WA, McDonald SA, Fanaroff AA, Vohr BR, Stoll BJ, Ehrenkranz RA et al (2011) Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 5 weeks’ gestation. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. JAMA 306:234858CrossRef
3.
Zurück zum Zitat Mori R, Kusuda S, Fujimura M (2011) Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation. Neonatal Research Network Japan. J Pediatr 159:110–114CrossRefPubMed Mori R, Kusuda S, Fujimura M (2011) Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation. Neonatal Research Network Japan. J Pediatr 159:110–114CrossRefPubMed
4.
Zurück zum Zitat Chawla S, Natarajan G, Rane S, Thomas R, Cortez J, Lua J (2010) Outcomes of extremely low birth weight infants with varying doses and intervals of antenatal steroid exposure. J Perinat Med 38:419–423CrossRefPubMed Chawla S, Natarajan G, Rane S, Thomas R, Cortez J, Lua J (2010) Outcomes of extremely low birth weight infants with varying doses and intervals of antenatal steroid exposure. J Perinat Med 38:419–423CrossRefPubMed
5.
Zurück zum Zitat Chawla S, Bapat R, Pappas A, Bara R, Zidan M, Natarajan G (2013) Neurodevelopmental outcome of extremely premature infants exposed to incomplete, no or complete antenatal steroids. J Matern Fetal Neonatal Med 26:1542–1547CrossRefPubMed Chawla S, Bapat R, Pappas A, Bara R, Zidan M, Natarajan G (2013) Neurodevelopmental outcome of extremely premature infants exposed to incomplete, no or complete antenatal steroids. J Matern Fetal Neonatal Med 26:1542–1547CrossRefPubMed
6.
Zurück zum Zitat American College of Obstetricians and Gynecologists (2016) Management of preterm labor. Practice Bulletin No. 171. Obstet Gynecol 128:155–164CrossRef American College of Obstetricians and Gynecologists (2016) Management of preterm labor. Practice Bulletin No. 171. Obstet Gynecol 128:155–164CrossRef
7.
Zurück zum Zitat Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane database of Systematic Reviews 2006, 3 Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane database of Systematic Reviews 2006, 3
8.
Zurück zum Zitat Aviram A, Guy L, Ashwal E, Hiersch L, Yogev Y, Hadar E (2016) Pregnancy outcome in pregnancies complicated with gestational diabetes mellitus and late preterm birth. Diabetes Res Clin Pract 113:198–203CrossRefPubMed Aviram A, Guy L, Ashwal E, Hiersch L, Yogev Y, Hadar E (2016) Pregnancy outcome in pregnancies complicated with gestational diabetes mellitus and late preterm birth. Diabetes Res Clin Pract 113:198–203CrossRefPubMed
9.
Zurück zum Zitat Gewolb IH, O’Brien J (1997) Surfactant secretion by type II pneumocytes is inhibited by high glucose concentrations. Exp Lung Res 23:245–255CrossRefPubMed Gewolb IH, O’Brien J (1997) Surfactant secretion by type II pneumocytes is inhibited by high glucose concentrations. Exp Lung Res 23:245–255CrossRefPubMed
10.
Zurück zum Zitat Gewolb IH (1996) Effect of high glucose on fetal lung maturation at different times in gestation. Exp Lung Res 22:201CrossRefPubMed Gewolb IH (1996) Effect of high glucose on fetal lung maturation at different times in gestation. Exp Lung Res 22:201CrossRefPubMed
11.
Zurück zum Zitat Cordero L, Treuer SH, Landon MB, Gabbe SG (1998) Management of infants of diabetic mothers. Arch Pediatr Adolesc Med 152:249–254CrossRefPubMed Cordero L, Treuer SH, Landon MB, Gabbe SG (1998) Management of infants of diabetic mothers. Arch Pediatr Adolesc Med 152:249–254CrossRefPubMed
12.
Zurück zum Zitat Persson B, Hanson U (1998) Neonatal morbidities in gestational diabetes mellitus. Diabetes Care 21:79–84CrossRef Persson B, Hanson U (1998) Neonatal morbidities in gestational diabetes mellitus. Diabetes Care 21:79–84CrossRef
13.
Zurück zum Zitat Pinter E, Peyman JA, Snow K et al (1991) Effects of maternal diabetes on fetal rat lung ion transport. Contribution of alveolar and bronchiolar epithelial cells to Na+, K(+)-ATPase expression. J Clin Investig 87:821CrossRefPubMed Pinter E, Peyman JA, Snow K et al (1991) Effects of maternal diabetes on fetal rat lung ion transport. Contribution of alveolar and bronchiolar epithelial cells to Na+, K(+)-ATPase expression. J Clin Investig 87:821CrossRefPubMed
14.
Zurück zum Zitat Carpenter MW, Coustan DR (1988) Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144:768–773CrossRef Carpenter MW, Coustan DR (1988) Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144:768–773CrossRef
15.
Zurück zum Zitat Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES (2005) Birth weight standards in the live-born population in Israel. Isr Med Assoc J 7:311–314PubMed Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES (2005) Birth weight standards in the live-born population in Israel. Isr Med Assoc J 7:311–314PubMed
16.
Zurück zum Zitat American College of Obstetricians and Gynecologists (2017) Antenatal corticosteroid therapy for fetal maturation. Committee Opinion No. 713. Obstet Gynecol 130:102–109CrossRef American College of Obstetricians and Gynecologists (2017) Antenatal corticosteroid therapy for fetal maturation. Committee Opinion No. 713. Obstet Gynecol 130:102–109CrossRef
17.
Zurück zum Zitat Gyamfi Bannerman C, Thom EA, Blackwell SC, Tita TN, Reddy UM, Saade GR et al (2016) Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med 374:1311–1320CrossRefPubMedPubMedCentral Gyamfi Bannerman C, Thom EA, Blackwell SC, Tita TN, Reddy UM, Saade GR et al (2016) Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med 374:1311–1320CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR et al (2008) Hyperglycemia and adverse pregnancy outcomes. HAPO Study Cooperative Research Group. N Engl J Med 358:1991–2002CrossRef Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR et al (2008) Hyperglycemia and adverse pregnancy outcomes. HAPO Study Cooperative Research Group. N Engl J Med 358:1991–2002CrossRef
19.
Zurück zum Zitat Refuerzo JS, Garg A, Rech B, Ramin SM, Vidaeff A, Blackwell SC (2012) Continuous glucose monitoring in diabetic women following antenatal corticosteroid therapy: a pilot study. Am J Perinatol 29:335–338CrossRefPubMed Refuerzo JS, Garg A, Rech B, Ramin SM, Vidaeff A, Blackwell SC (2012) Continuous glucose monitoring in diabetic women following antenatal corticosteroid therapy: a pilot study. Am J Perinatol 29:335–338CrossRefPubMed
20.
Zurück zum Zitat Wapner RJ, Sorokin Y, Thom EA, Johnson F, Dudley DJ, Spong CY et al (2006) Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Am J Obstet Gynecol 195:633–642CrossRefPubMed Wapner RJ, Sorokin Y, Thom EA, Johnson F, Dudley DJ, Spong CY et al (2006) Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Am J Obstet Gynecol 195:633–642CrossRefPubMed
21.
Zurück zum Zitat Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS (2006) Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Lancet 367:1913–1919CrossRefPubMed Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS (2006) Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Lancet 367:1913–1919CrossRefPubMed
22.
Zurück zum Zitat Battin M, Bevan C, Harding J (2012) Growth in the neonatal period after repeat courses of antenatal corticosteroids: data from the ACTORDS randomized trial. Arch Dis Child Fetal Neonatal Ed 97:99–105CrossRef Battin M, Bevan C, Harding J (2012) Growth in the neonatal period after repeat courses of antenatal corticosteroids: data from the ACTORDS randomized trial. Arch Dis Child Fetal Neonatal Ed 97:99–105CrossRef
23.
Zurück zum Zitat Espinoza J, Kusanovic JP, Kim CJ, Kim YM, Kim JS, Hassan SS et al (2007) An episode of preterm labor is a risk factor for the birth of a small-for-gestational-age neonate. Am J Obstet Gynecol 196:574PubMedPubMedCentral Espinoza J, Kusanovic JP, Kim CJ, Kim YM, Kim JS, Hassan SS et al (2007) An episode of preterm labor is a risk factor for the birth of a small-for-gestational-age neonate. Am J Obstet Gynecol 196:574PubMedPubMedCentral
24.
Zurück zum Zitat Modanlou HD, Dorchester WL, Thorosian A, Freeman RK (1980) Macrosomia—maternal, fetal and neonatal implications. Obstet Gynecol 55:420–424PubMed Modanlou HD, Dorchester WL, Thorosian A, Freeman RK (1980) Macrosomia—maternal, fetal and neonatal implications. Obstet Gynecol 55:420–424PubMed
25.
Zurück zum Zitat Spellacy WN, Miller S, Winegar A, Peterson PQ (1985) Macrosomia—maternal characteristics and infant complications. Obstet Gynecol 66:158–161PubMed Spellacy WN, Miller S, Winegar A, Peterson PQ (1985) Macrosomia—maternal characteristics and infant complications. Obstet Gynecol 66:158–161PubMed
26.
Zurück zum Zitat Bérard J, Dufour P, Vinatier D, Subtil D, Vanderstichèle S, Monnier JC et al (1998) Fetal macrosomia: risk factors and outcome. A study of the outcome concerning 100 cases > 4500 g. Eur J Obstet Gynecol Reprod Biol 77:51–59CrossRefPubMed Bérard J, Dufour P, Vinatier D, Subtil D, Vanderstichèle S, Monnier JC et al (1998) Fetal macrosomia: risk factors and outcome. A study of the outcome concerning 100 cases > 4500 g. Eur J Obstet Gynecol Reprod Biol 77:51–59CrossRefPubMed
27.
Zurück zum Zitat Lazer S, Biale Y, Mazor M, Lewenthal H, Insler V (1986) Complications associated with the macrosomic fetus. J Repro Med 31:501–505 Lazer S, Biale Y, Mazor M, Lewenthal H, Insler V (1986) Complications associated with the macrosomic fetus. J Repro Med 31:501–505
28.
Zurück zum Zitat Menticoglou SM, Manning FA, Morrison I, Harman CR (1992) Must macrosomic fetuses be delivered by a cesarean section? A review of outcome for 786 babies ≥ 4,500 g. Aust N Z J Obstet Gynaecol 32:100–103CrossRefPubMed Menticoglou SM, Manning FA, Morrison I, Harman CR (1992) Must macrosomic fetuses be delivered by a cesarean section? A review of outcome for 786 babies ≥ 4,500 g. Aust N Z J Obstet Gynaecol 32:100–103CrossRefPubMed
29.
Zurück zum Zitat Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. N Engl J Med 352:2477–2486CrossRefPubMed Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. N Engl J Med 352:2477–2486CrossRefPubMed
30.
Zurück zum Zitat Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B et al (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. N Engl J Med 361:1339–1348CrossRefPubMedPubMedCentral Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B et al (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. N Engl J Med 361:1339–1348CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L (2013) Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med 159:123–129CrossRefPubMed Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L (2013) Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med 159:123–129CrossRefPubMed
Metadaten
Titel
Neonatal outcome in gestational-diabetic mothers treated with antenatal corticosteroids delivering at the late preterm and term
verfasst von
Eyal Krispin
Alyssa Hochberg
Rony Chen
Arnon Wiznitzer
Eran Hadar
Adi Borovich
Publikationsdatum
05.07.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2018
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-018-4848-8

Weitere Artikel der Ausgabe 4/2018

Archives of Gynecology and Obstetrics 4/2018 Zur Ausgabe

Gynecologic Endocrinology and Reproductive Medicine

Galectin-3 as a novel biomarker in women with PCOS

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.